Management doesn't think it's much of a priority to meet timeframes provided or update shareholders. What's going on with GR's report and the optimised downstream DFS?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025